The NOTA ligand was known to form stable complexes with Al3+ [20], and thus, the commercially available S-2- 4-isothiocyanatobenzyl -1,4,7-triazacyclononane-1,4,7-triacetic S-2- 4-isothiocyanatobenzyl -1,4,7-triazacyclononane-1,4,7-triaceticIMP449, S-2- 4-isothiocyanatobenzyl -1,4,7-triazacyclononane-1,4,7-triacetic
The NOTA-XS670-HSAMS were washed with 2 M NH4OAc.
By taking advantage of the plasmonic properties of AuNPs imaging, the NOTA-Au-IONP-Affibody could be used for cell assays with a scanning confocal microscope.
The NOTA-affibody ZHER2 2395 (58 amino acids, 7 kDa) was labeled at 90°C for 15 min with Al18F, with acetonitrile as a cosolvent [45].
The NOTA-Au-IONP-Affibody was very stable in 10% fetal bovine serum in PBS at 37°C for 48 h with little variation of particle size.
The right to left hemisphere ratios remained constant across the different concentrations of unlabeled conjugates and exceed that obtained with the control 64Cu-NOTA-antibody.
The labeling yields (expressed as percentage of the amount of radioactivity at the start) after 99mTc labeling, purification, and washing steps were in the following order: MBs functionalized with DTPA, 60%; MBs functionalized with PMAA, 45%; MBs functionalized with NOTA, 42%; and MBs functionalized with chitosan, 25%; while the labeling of plain MBs yielded about 20%.
SPION was incorporated between the layers of PVA MBs followed by ligand coupling with DTPA or NOTA to enable the multimodality imaging of MBs using SPECT and MRI.
On the other hand, Ga III) displays a reverse behavior, forming more stable complexes with NOTA than with DOTA (Majkowska-Pilip & Bilewicz 2011; Notni et al. 2012).
